CD274 and triple-negative breast carcinoma: It has been reported that the association of PD-L1 expression with poor prognosis was mainly found in triple negative breast cancer, [30, 31] and we speculated that simeprevir could effectively down-regulate the expression of PD-L1 in MDA-MB-468 cells exhibiting triple negative subtype.